Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey
Objective This study aimed to investigate the preferences regarding risks, benefits and other treatment attributes of patients with type 2 diabetes mellitus (T2DM) in China when selecting a second-line anti-hyperglycaemic medicine.Methods A discrete choice experiment with hypothetical anti-hyperglyc...
Main Authors: | Jing Liu, Lei Si, Yingyao Chen, Yanfeng Ren, Liu Liu, Shimeng Liu, Qi Pan, Xiong Ke, Shiyi Bao, Fuming Li, Yijiang Yu, Yan Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-04-01
|
Series: | BMJ Global Health |
Online Access: | https://gh.bmj.com/content/8/4/e010942.full |
Similar Items
-
Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study
by: Yue Teng, et al.
Published: (2023-09-01) -
A Systematic Review of Medication Preferences for Patients with Depression Based on Discrete Choice Experiment and Best-worst Scaling
by: REN Yanfeng, LIU Shimeng, TAO Ying, CHEN Yingyao
Published: (2023-10-01) -
Anti-hyperglycaemic activity of tuber extract of Chlorophytum alismifolium Baker in streptozotocin-induced hyperglycaemic rats
by: Abdulhakim Abubakar, et al.
Published: (2018-06-01) -
Glyoxal in hyperglycaemic ischemic stroke – a cohort study
by: Sina Rhein, et al.
Published: (2023-07-01) -
Second-line Medication Preference in Patients with Type 2 Diabetes: a Study Based on a Discrete Choice Experiment
by: LIU Zhigang, LIU Shimeng, ZHENG Lyuyun, XUE Wenjing, CAO Chenchen, LIU Jing, CHEN Yingyao
Published: (2024-01-01)